Predict your next investment

INDUSTRIAL | Basic Materials / Specialty Chemicals
tyratech.com

See what CB Insights has to offer

Stage

Acq - P2P | Acquired

About TyraTech

TyraTech develops technology to effectively control insects and parasites while providing a of safety for people, animals and the environment. TyraTech's scientific process targets receptors active only in invertebrates, not in humans or animals. TyraTech leverages this scientific platform to develop natural products that are as effective as traditional chemical options.On December 31st, 2019, TyraTech was acquired by American Vanguard, terms of the transaction were not disclosed.

TyraTech Headquarter Location

5151 Mccrimmon Parkway Suite 275

Morrisville, North Carolina, 27560,

United States

919-415-4300

Latest TyraTech News

American Vanguard Announces Acquisition of Tyratech, Inc.

Nov 5, 2018

November 05, 2018 09:00 AM Eastern Standard Time NEWPORT BEACH, Calif.--( BUSINESS WIRE )--American Vanguard Corp. (NYSE:AVD) announced that it will acquire all of the outstanding shares of Tyratech, Inc. (AIM: TYRU and TYR). During a special meeting of shareholders conducted on October 31, 2018, Tyratech’s shareholders approved both (i) an agreement and plan of merger and (ii) the cancellation of admission of Tyratech’s common stock to trading on the AIM market of the London Stock Exchange. Tyratech is a life sciences company focused on nature-derived insect and parasite control products. Prior to the transaction, American Vanguard held approximately 35% of the shares of Tyratech. The transaction, including de-listing of Tyratech shares from the AIM market, is expected to close on November 8, 2018. Further details of the deal were not disclosed. Eric Wintemute, Chairman and CEO of American Vanguard, stated, “We are excited to have acquired Tyratech, which has spent over a decade developing non-toxic insecticides and green solutions for pest control. Their patented technology platform leverages synergistic essential oil combination to target invertebrate pest receptors that are not active in humans and other mammals. Thus, they are highly effective and safe for use around people and pets. This acquisition complements our Envance portfolio, which uses the same technology platform in consumer, professional and agricultural applications, and will enable us to expand our market into mosquito repellent, animal health and other sectors.” About American Vanguard American Vanguard Corporation is a diversified specialty and agricultural products company that develops and markets products for crop protection and management, turf and ornamentals management and public and animal health. American Vanguard is included on the Russell 2000® & Russell 3000® Indexes and the Standard & Poors Small Cap 600 Index. To learn more about American Vanguard, please reference the Company’s web site at www.american-vanguard.com . In its public commentary, the Company may discuss forward-looking information. Except for the historical information contained in this release, all forward-looking statements are estimates by the Company’s management subject to various risks and uncertainties that may cause results to differ from management’s current expectations. Such factors include weather conditions, changes in regulatory policy and other risks as detailed in the Company’s SEC reports and filings. All forward-looking statements, if any, in this release represent the Company’s judgment as of the date of this release.

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

TyraTech Patents

TyraTech has filed 22 patents.

The 3 most popular patent topics include:

  • Acetylcholinesterase inhibitors
  • Flavors
  • Monoterpenes
patents chart

Application Date

Grant Date

Title

Related Topics

Status

5/19/2017

9/14/2021

Acetylcholinesterase inhibitors, Lice, Organophosphate insecticides, Insecticides, Medicinal plants

Grant

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Application Date

5/19/2017

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Grant Date

9/14/2021

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Title

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Related Topics

Acetylcholinesterase inhibitors, Lice, Organophosphate insecticides, Insecticides, Medicinal plants

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Grant

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.